Upgrade to SI Premium - Free Trial

NextCure Inc. (NXTC)

2.23 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

NXTC makes replay available for event on cancer drug trial data June 4, 2026 8:01 AM - StreetInsider NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers June 4, 2026 8:00 AM - StreetInsider Form 8-K NextCure, Inc. For: Jun 01 June 1, 2026 8:11 AM - SEC Filing NextCure reports positive SIM0505 trial data for gynecologic cancers June 1, 2026 8:01 AM - StreetInsider NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026 June 1, 2026 8:00 AM - StreetInsider Form SCHEDULE 13G/A NextCure, Inc. Filed by: SILVERARC CAPITAL MANAGEMENT, LLC May 13, 2026 4:42 PM - SEC Filing Lucid Capital Markets Starts NextCure Inc. (NXTC) at Buy May 11, 2026 7:10 AM - StreetInsider NextCure Inc. (NXTC) Misses Q1 EPS by 187c May 8, 2026 5:42 AM - StreetInsider Form 10-Q NextCure, Inc. For: Mar 31 May 7, 2026 4:30 PM - SEC Filing Form 8-K NextCure, Inc. For: May 07 May 7, 2026 4:22 PM - SEC Filing NextCure Provides Business Update and Reports First Quarter 2026 Financial Results May 7, 2026 4:05 PM - StreetInsider Form SCHEDULE 13G/A NextCure, Inc. Filed by: Simcere Zaiming, Inc. May 6, 2026 9:27 PM - SEC Filing NextCure begins dose optimization study for ovarian cancer drug May 4, 2026 7:05 AM - StreetInsider NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers May 4, 2026 7:05 AM - Globe NewsWire Form DEFA14A NextCure, Inc. April 24, 2026 4:19 PM - SEC Filing Form DEF 14A NextCure, Inc. For: Jun 18 April 24, 2026 4:16 PM - SEC Filing NextCure to present SIM0505 cancer drug data at ASCO 2026 April 21, 2026 10:15 AM - StreetInsider NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026 April 21, 2026 10:15 AM - StreetInsider NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer April 7, 2026 12:45 PM - Globe NewsWire NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer April 7, 2026 8:15 AM - StreetInsider NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026 March 31, 2026 4:05 PM - StreetInsider Full Article List